Email ID
Password
Sign me in automatically next time
clinica
Market Sector - Orthopaedics
28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
14 July 2011
Stryker will no longer distribute Corin’s Cormet metal-on-metal resurfacing hip system in the US, after the orthopaedics firms terminated a partnership dating back to 2005. Cirencester, UK-based Corin, which said the decision “was made in line with ...
23 June 2011
In a sobering review of UK hip fracture care, the National Institute for Health and Clinical Excellence (NICE) has issued guidelines that seek to ensure that patients are operated on the same day of admission or the following day. Citing evidence ...
01 March 2011
Medtronic has terminated five contracts with Novation, the largest US healthcare group purchasing organisation (GPO). The contracts cover cardiovascular and orthopaedic products and are worth around $2bn in annual purchases. GPOs act as "middlemen", ...
22 February 2011
Smith & Nephew has launched its Short Modular Femoral (SMF) Hip system, a modular total hip replacement stem system for patients with osteoarthritis. Made from cobalt chromium, the SMF Hip is 20% shorter than conventional hip stems and allows the ...
 
12 January 2009
Osiris Therapeutics has gained a $5m milestone payment after hitting the first production target of a supply agreement it has with NuVasive for a bone matrix product (BMP). This pact stems from Osiris’ sale of its Osteocel BMP to NuVasive in July ...
 
23 June 2011
Japan w ants to develop its medtech industry. So how well does it support the technologies in which it already has a stake? If one was look into the field of joint navigation for an answer, they would find that the response is “Not very well”, ...
12 May 2009
The automated cell and tissue engineering system (ACTES) developed by Octane Biotech has myriad possible applications, from skin grafts to implants – but its real advantage is its scalability. So said Tim Smith, CEO of the Toronto-based firm's ...
05 May 2009
In a bid to conserve cash reserves, manufacturer of biodegradable medical implants Inion has set a timetable for de-listing from the London Stock Exchange’s Alternative Investment Market (AIM). Over recent months, the company has been struggling to ...
 
12 May 2009
Rusalatide acetate (Chrysalin ® ) is an investigational drug being evaluated for treatment of chronic wounds and fractures. Rusalatide acetate interacts with cell surface receptors to stimulate a cascade of cellular and molecular wound healing ...
01 October 2008
Rusalatide acetate (Chrysalin ® ) is an investigational drug being evaluated for treatment of chronic wounds and fractures. Rusalatide acetate interacts with cell surface receptors to stimulate a cascade of cellular and molecular wound healing ...
01 October 2008
Background: Statins are 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors and have been shown to possess anti-lipidaemic properties effective in lowering cholesterol. Recent evidence has suggested beneficial pleiotropic effects, including ...
 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
MEDICAL TECHNOLOGY


Loading MEDICAL TECHNOLOGY ....
 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36